Readers Digest
Magazine subscription Podcast
HomeHealthHealth Conditions

Weight Loss Program: Why Personalised Support Matters

2 min read

Weight Loss Program: Why Personalised Support Matters
The battle against obesity is a complex one, and new research suggests that a key weapon in this fight, GLP-1 medications, may be even more effective when paired with personalised support.
A UK study published in the Journal of Diabetes, Obesity and Metabolism compared the results of patients using GLP-1 medications alone to those using the medications in conjunction with a personalised weight-loss program offered by the digital healthcare brand, Juniper. The findings are promising news for anyone struggling with weight loss and considering GLP-1 therapy.

GLP-1: A Promising Tool, But Not a Magic Bullet

GLP-1 medications like Ozempic have taken the weight-loss world by storm. These medications mimic a natural hormone that helps regulate appetite and blood sugar. While GLP-1s represent a significant advancement in the fight against obesity, the Juniper study highlights that for optimal results, they should be part of a broader approach.

The Juniper Difference: Personalised Support Drives Results

The study compared three groups: patients taking GLP-1 medications with standard diet and exercise advice (similar to traditional treatment), patients taking GLP-1 medications without additional support, and patients using Juniper's digital weight-loss program alongside GLP-1 medications.
The results were impressive. Patients in the Juniper program were:
  • Twice as likely to lose at least 15% of their body weight, and achieve this in a shorter timeframe.
  • Nearly 90% were successful in losing at least 5% of their body weight within 32 weeks.
  • One quarter achieved a significant weight loss (at least 15%) within the same timeframe.
These findings highlight the power of personalised support in maximising the effectiveness of GLP-1 medications. Juniper's program goes beyond medication, offering patients access to a team of healthcare experts, including dietitians, health coaches, and medical professionals, who create a tailored plan for each individual. This holistic approach addresses not just the "what" (diet and exercise) but also the "how" (support, guidance, and behaviour change strategies).

Making Weight Loss Accessible: Digital Solutions Bridge the Gap

The high cost of a team of in-person specialists often makes comprehensive weight-loss programs out of reach for many. This is where digital healthcare platforms like Juniper shine. They offer a convenient and affordable alternative, providing personalised support and guidance remotely.

The Road to Long-Term Weight Management

The key takeaway from this study is that successful weight loss is not a one-size-fits-all endeavour. GLP-1 medications are a powerful tool, but they work best when combined with a personalised approach that addresses both the physiological and behavioural aspects of weight management. Platforms like Juniper offer a promising solution, empowering individuals to achieve lasting weight loss and improve their overall health.
Important Note: It's important to consult with your doctor to determine if GLP-1 medications are right for you. This article is for informational purposes only and should not be taken as medical advice.

This post contains affiliate links, so we may earn a small commission when you make a purchase through links on our site at no additional cost to you. Read our disclaimer

Loading up next...
Stories by email|Subscription
Readers Digest

Launched in 1922, Reader's Digest has built 100 years of trust with a loyal audience and has become the largest circulating magazine in the world

Readers Digest
Reader’s Digest is a member of the Independent Press Standards Organisation (which regulates the UK’s magazine and newspaper industry). We abide by the Editors’ Code of Practice and are committed to upholding the highest standards of journalism. If you think that we have not met those standards, please contact 0203 289 0940. If we are unable to resolve your complaint, or if you would like more information about IPSO or the Editors’ Code, contact IPSO on 0300 123 2220 or visit ipso.co.uk